Northeastern law firm McCarter & English has hired two intellectual property attorneys for its office in Newark, New Jersey from Wolff & Samson PC.
Bolstered by a slew of new pharmaceutical clients, Brown Raysman Millstein Felder & Steiner LLP has seen the revenues from its intellectual property practice nearly double in the past 18 months.
One day after Canadian memory chip maker Mosaid Technologies settled its patent infringement lawsuit against South Korean rival Samsung Electronics, the company said it had filed a similar suit against Korea’s Hynix Semiconductor Inc.
U.K. drug maker GlaxoSmithKline Plc’s patent lawsuit against Israeli generics maker Teva Pharmaceutical Industries Ltd. over its best-selling anti-epileptic drug Lamictal will be heard in a U.S. court on Tuesday.
South Korea’s Samsung Electronics has agreed to take a license to settle an increasingly embarrassing patent infringement lawsuit brought by Canadian memory-chip maker Mosaid Technologies.
A New Jersey company that rebuilds used Fuji Photo Film Co. disposable cameras and sells them without brand names at a discount is infringing Fuji’s patent rights, the U.S. Court of Appeals for the Federal Circuit has affirmed.
A federal district court has ruled that Teva Pharmaceuticals’s generic moexipril infringes a patent held by Schwarz Pharma for the hypertension drug Univasc.
For Gibbons, Del Deo, the key to attracting the right intellectual property attorneys has been a steadfast focus on corporate America.
Former federal intellectual property crime prosecutor Scott S. Christie has joined McCarter & English, LLP, as a partner in the firm’s Newark office.
A U.S. federal judge has denied the appeal of the remaining two sanctions against Samsung Electronics Co. for destroying evidence in a patent dispute with Canadian rival Mosaid Technologies Inc.
In a decision that could represent the final blow to an aggressive licensing program by LG Electronics, a federal judge in Northern California has thrown out the Korean electronics maker’s four-year patent lawsuit against U.S. and Taiwanese makers of computers and motherboards.
Townsend and Townsend and Crew has quietly settled a lawsuit that accused the California intellectual-property law firm of legal malpractice, breach of fiduciary duty and breach of contract over a decade of service.
International law firm Kelley Drye & Warren has staffed up in Chicago and is launching a new patent group to bolster its intellectual property practice.
In a sign of the increasing litigation over lucrative patent rights for digital cameras, four of the world’s top camera makers are trying to fend off a lawsuit by a tiny Michigan company that already has won large jury awards against major photography companies such as Canon Inc. and Sony Corp.
A Missouri federal court has ruled that a plaintiff that did not respond to a cease and desist letter and instead filed a declaratory action in federal court cannot take advantage of the first-filed rule.
Canadian telecom company Nortel Networks Corp. has settled a copyright and trade secrets case it brought in July against Arbinet-thExchange Inc., an internet-based business-to-business trading exchange.
Dutch drug maker Akzo Nobel has agreed to pay $36 million to settle a class-action lawsuit brought by U.S. states and public sector health purchasers over an alleged attempt to evergreen patents on the former blockbuster antidepressant Remeron.
A federal district court judge has denied drug maker Pfizer Inc.'s motion for a preliminary injunction to block Alpharma's sale of a generic version of epilepsy drug Neurontin.
In a risky move, Alpharma Inc. on Friday launched a generic version of Pfizer’s blockbuster epilepsy drug Neurontin without waiting for a court ruling on Pfizer's motion for a preliminary injunction.
A hearing on Pfizer’s motion for a preliminary injunction against a generic version of epilepsy drug Neurontin was adjourned Thursday with no decision.